Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:50 AM
Ignite Modification Date:
2025-12-25 @ 4:50 AM
NCT ID:
NCT06472518
Eligibility Criteria:
Inclusion Criteria:
* Patients who agreed to participate in the study and gave oral consent.
* Patient affiliated to a social security scheme
* Iliac and/or common femoral venous thrombosis
* Recent thrombosis less than or equal to 14 days since qualifying imaging or less than or equal to 21 days since onset of symptoms
And at least 1 of the following criteria:
* Visual analog scale greater than or equal to 5 and/or
* Venous claudication and/or
* Increase in thigh circumference greater than or equal to 5% compared with contralateral thigh.
Exclusion Criteria:
* Patients with superficial femoral or popliteal venous thrombosis without involvement of the common femoral or iliac veins.
* Patients with isolated thrombosis of the inferior vena cava, without extension to the iliac veins.
* Thrombosis of inferior vena cava proximal to the renal veins.
* Minors, pregnant women, adults under guardianship.
* Chronic renal failure with creatinine clearance below 30ml/min according to Cockroft.
* Ischaemic phlebitis: proximal venous thrombosis associated with limb ischemia and impaired arterial flow.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06472518
Study Brief:
Protocol Section:
NCT06472518